Cell competition for cancer treatment with Urine Progenitor Cells
J. R. Bago, D. Radhakrishnan, M. Hrdinka, T. Cichon, R. Smolarczyk, S. Charvatova, B. Motais, S. Giebel, R. Hajek
This study shows urine progenitor cells (UPCs) can be engineered to have antitumor properties through cell-cell competition, reducing tumor volume in a mouse model of breast cancer.
bioRxiv · Aug 27, 2023 · PreprintCancer Biology